Bladder disorders associated with interstitial cystitis are frequently characterized by increased contractility and pain. The goals of this study were to examine 1) the effects of blocking proteinase-activated receptor-2 (PAR2) on the exaggerated bladder activity and pain evoked by cystitis and 2) the underlying mechanisms responsible for the role of PAR2 in regulating cystic sensory activity. The protein expression of PAR2 was amplified in rats with cystitis by inducing it with systemic administration of cyclophosphamide (CYP) as compared with control rats. Blocking PAR2 by intrathecal infusion of PAR2 antagonist FSLLRY-NH2 attenuated bladder hyperactivity and pain. In addition, blocking PAR2 attenuated the transient receptor potential A1 (TRPA1) signal pathway, whereas inhibition of the TRPA1 decreased bladder hyperactivity and pain. The data revealed specific signaling pathways leading to CYP-induced bladder hyperactivity and pain, including the activation of PAR2 and TRPA1. Inhibition of these pathways alleviates cystic pain. Targeting one or more of these signaling molecules may present new opportunities for treatment and management of overactive bladder and pain often observed in cystitis.
Introduction
Interstitial cystitis, also known as bladder pain syndrome (IC/BPS) is a chronic pathological condition of the bladder characterized by symptoms such as pelvic pain, urgency or frequency in urination [1] . IC/BPS impacts normal physical and mental health and presents a remarkable negative effect on the quality of life of patients [1] . Patients with IC/ BPS constantly feel pain at normal bladder pressures, suggesting amplified excitability of their micturition reflex pathway [2] . This is likely due to an impairment of the sensory inputs that originated from the bladder to the spinal cord and central nervous system. Nonetheless, treatment options for cystic pain have been limited, partly due to our poor understanding of the underlying mechanisms responsible for pain.
Proteinase-activated receptors (PARs) are a family member of G-protein-coupled receptors and are activated by a proteolytic mechanism [3] . Among the four members of PARs, PAR2 is largely distributed in various tissues, including skin, gastrointestinal, cardiovascular, and respiratory systems. Of note, about 60% of sensory dorsal root ganglion (DRG) neurons at the spinal L4-L6 levels contain PAR2 [4, 5] .
Stimulation of PAR2 by peripheral or central administration of non-inflammatory doses of PAR2 agonists evokes mechanical and thermal hyperalgesia in rats [6] . The studies further suggest that the release of substance P and calcitonin gene-related peptide (CGRP) contribute to acute and chronic pain by activation of PAR2 [6] . In experimental animal models, the expression of PAR2 is upregulated in the dorsal horn of the spinal cord after induction of pain and blocking spinal PAR2 eliminates mechanical and thermal hyperalgesia [7] . Nevertheless, it has not been reported that PAR2 pathways specifically contribute to cystitis-induced hyperalgesia.
The underlying mechanisms responsible for the role of PAR2 in regulating cystitis-evoked neuropathic pain should also be studied.
The superficial dorsal horn is the first synaptic site from peripheral afferent nerves to the central nervous system [8, 9] and plays an important role in modulating pain [10, 11] .
Specifically, the dorsal horn at the lumbar levels (i.e., L5 to L6) is the first synaptic site receiving (sharing) pain inputs from both visceral organs (i.e., bladder) and the hind paw. Thus, in this study we determined the role played by PAR2 at this level of lumbar superficial dorsal horn in regulating bladder hypersensitivity and mechanical hyperalgesia in rats following cystitis induced by systemic administration of cyclophosphamide (CYP). In a cystitis model of CYP, the rats' bladders appear to be hyperactive with an elevated voiding pressure, which leads to mechanical pain [12, 13] . In general, mechanical paw withdrawal threshold (PWT) of a rat's hind paw in response to the stimulation of von Frey filaments was employed to assess mechanical pain under pathophysiological conditions [14] . 
Materials and methods

Animals
Induction of cystitis
Rats were intraperitoneally (i.p.) injected with CYP (75 mg/kg, in the concentration of 75 mM, Sigma-Aldrich, St. Louis, MO, USA) every 3 days to induce chronic cystitis [12, 13] . On the eighth day experiments were performed. Control rats received saline injections.
Bladder catheterization
Rats were treated perioperatively for 96 hours with trimethoprim-sulfamethoxazole 
Intrathecal catheter for administration of drugs
After completion of the bladder catheter implantation, one end of polyethylene-10 tubing was inserted intrathecally through an incision in the cisternal membrane and advanced 7-9 cm caudally until the tip of the catheter was positioned at the lumbar spinal level (L5 to L6). The other end of the intrathecal tubing was sutured to the musculature and skin at the incision site and externalized to the back of the rat. Animals were allowed to recover and then returned to the animal care facility where they were housed individually. Five days were allowed before the experiments were performed.
Mechanical sensitivity and cystometry
In this study, all experiments were performed in a double-blinded manner. On the day of experimentation, individual rats were placed in a Plexiglas chamber (25 × 8 × 9 cm) with a wire mesh floor. The bladder catheter was connected to a three-way stopcock connected to an infusion pump and pressure transducer. and HC030031 was 100 μl. An infusion pump was used to deliver those vehicles and drugs constantly over a period of 30 min. Note that a prior study using the same approach was used to intrathecally infuse respective FSLLRY-NH2 and HC030031 and it was shown that 10 µg of FSLLRY-NH2 and HC030031 were effective to attenuate mechanical hyperalgesia [6] .
Ten min after intrathecal infusion, mechanical sensitivity of the hindpaws was again determined. Post-treatment cystometry was also performed after completion of mechanical sensitivity examination. Thus, six groups were included in this study as: saline 
Statistical analysis
Data for mechanical threshold, voiding pressure and intercontraction interval were analyzed using a two-way repeated-measure ANOVA since multiple interventions were compared among groups. Data for western blot analysis were analyzed by using a two sample t-test.
Values were presented as means ± standard deviation. For all analyses, differences were considered significant at P < 0.05. All statistical analyses were performed by using SPSS 13.0 (SPSS Inc., Chicago, IL, USA). Figure 1A shows the protein expression of PAR2 in saline control rats (n = 6) and CYP-rats (n = 8).
Results
Expression of PAR2 in spinal cord of control rats and CYP-rats
CYP significantly increased the protein levels of PAR2 in the superficial dorsal horn as compared with control rats (P < 0.05, CYP-rats vs. control rats).
Effects of PAR2 on mechanical hypersensitivity and bladder activity
After all the data of mechanical sensitivity and cystometry was obtained, control vehicle and FSLLRY-NH2 was intrathecally infused. Figure   1B shows that CYP decreased PWT in rats with vehicle infusion (P < 0.05 vs. saline control; n = 12) compared with saline control rats (n = 9). As FSLLRY-NH2 (n = 15) was infused, a decrease in PWT evoked by CYP was blunted (P < 0.05
vs. CYP-rats with vehicle infusion). Note that
there was no changes of PWT observed in saline control rats after infusion FSLLRY-NH2
(n = 8), suggesting that blocking PAR2 had no significant effects on mechanical sensitivity in rats under normal bladder conditions. Figure 2A shows the protein expression of TRPA1 in saline control rats and CYP-rats (n = 6 in each group). CYP significantly increased the protein levels of TRPA1 in the superficial dorsal horn as compared with control rats (P < 0.05 vs. control rats). Furthermore, Figure   2A demonstrates that the amplified expression of TRPA1 evoked by CYP was significantly attenuated (n = 8) when FSLLRY-NH2 was infused into the spinal cord of CYP-rat.
TRPA1 signal pathway engaged in effects of PAR2
We also examined the effects of blocking TRPA1 on mechanical hypersensitivity and bladder activity. Additional results suggest that PAR2 signaling plays a critical role in regulating TRPA1 and TRPV1, thereby leading to mechanical allodynia and thermal hyperalgesia [6, 7] . Moreover, PLC, PKA and PKC intracellular signaling pathways are involved in the role of PAR2 [6, 7] . In our current study, it was observed that CYP amplifies expression of PAR2 in the superficial dorsal horn and speculatively this is likely to activate PLC, PKA and PKC signaling pathways, which then lead to increases of TRPA1 and/or TRPV1 and regulate mechanical hyperalgesia in this rat model of cystitis.
TRPA1 also has a functional role in pain and neurogenic inflammation resulting from channel activation to a variety of compounds including pungent agents, irritant chemicals, reactive oxygen and nitrogen species, and products of oxidative stress-induced lipid peroxidation [18] [19] [20] [21] . TRPA1 has been shown to co-localize with TRPV1 in subpopulations of sensory neurons [20] and is engaged in development of bradykinin-induced mechanical hypersensitivity [22, 23] and painfully cold temperatures [24] . Our evidence from the current study supports the notion It is well known that stimulation of nociceptive receptors in the sensory nerves leads to the releases of substance P and CGRP from the nerve terminal of dorsal root ganglions into the superficial dorsal horn [25] . Numerous receptors present on the presynaptic site of the nerve terminals contribute to the release of substance P and CGRP, thus regulating inflammatory pain [11] . Specifically, our recent study suggests that substance P and CGRP in the dorsal horn are engaged in CYPinduced bladder mechanical hyperalgesia [26] .
Inhibition of the PAR2 signal pathway can affect the levels of substance P and CGRP in the dorsal horn and alter the process of pain responses.
Thus, it is speculated that blocking PAR2 can decrease the levels of those two neuropeptides in the dorsal horn of the spinal cord of CYP-rats.
Moreover, it needs to be acknowledged that we studied female rats in the present study because the prevalence of IC/PBS among women is estimated to be 2 to 5 times higher than in men [1] . Also, it should be noted that the levels of estrogen generally affect pain sensitivity. However, the estrus cycle was not examined during behavioral experiments in the present study. This could be considered as a limitation of this study. 
